InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 11/03/2020 2:00:21 PM

Tuesday, November 03, 2020 2:00:21 PM

Post# of 5918
Breaking News: $GWPH GW Pharmaceuticals Initiates Phase 3 Trial for Multiple Sclerosis Drug

GW Pharmaceuticals (NASDAQ: GWPH) announced today that it is starting up its phase 3 trial for nabiximols, an oral spray for patients who have spasticity associated with multiple sclerosis (MS). Nabiximols is a botanical medicine derived from cannabis plants. The drug, sold as Sativ...

Find out more GWPH - GW Pharmaceuticals Initiates Phase 3 Trial for Multiple Sclerosis Drug

@whytestocks